- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Novavax Inc+ Add to Watchlist
NVAX:US8.8900 USD 0.0200 0.23%
As of 20:10:00 ET on 05/26/2015.
Company Profile for Novavax Inc (NVAX)
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Key Executives for Novavax Inc (NVAX)
|Stanley C ErckPresident/CEO||Barclay A Phillips "Buck"Senior VP/CFO/Treasurer|
|John A Herrmann IIISenior VP/Secy/Gen Cnsl||Russell P Wilson "Rip"Senior VP:Business Development|
|John J TrizzinoSenior VP:Commercial Operations||Gregory M Glenn "Greg"Senior VP:Research & Development|
|Timothy J HahnSenior VP:Manufacturing Ops|